During the past decade, Dubin Breast Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dubin Breast Center" are "Breast Cancer" (1 trials), "Metastasis" (1 trials) and "Ovarian Neoplasms" (1 trials). Many other conditions were trialed in "Dubin Breast Center" in a lesser frequency.

Most popular intervention types in "Dubin Breast Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (1 trials), "Bicalutamide" (1 trials), "Ipatasertib" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dubin Breast Center" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Dubin Breast Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Dubin Breast Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dubin Breast Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".